Jurickson Profar’s Suspension: A Deep Dive into MLB’s PED Landscape
Atlanta Braves outfielder Jurickson Profar has received a 162-game suspension for testing positive for exogenous testosterone and its metabolites, marking his second violation of Major League Baseball’s Joint Drug Prevention and Treatment Program in just over a year. While the Players Association is appealing the decision, the suspension throws a spotlight on the ongoing battle against performance-enhancing drugs (PEDs) in baseball and raises questions about the future of drug testing and enforcement.
The Escalating Penalties for PED Employ
Profar’s case highlights the increasingly severe penalties for repeat offenders. His initial suspension in 2025 was for 80 games after testing positive for human chorionic gonadotropin (hCG), a substance often used after steroid cycles. The current suspension, a full season ban, underscores MLB’s commitment to deterring PED use. Since 2014, a second positive test results in a 162-game suspension, effectively wiping out a player’s season and potentially impacting their career.
Financial Implications for Players and Teams
The financial consequences of these suspensions are substantial. Profar stands to forfeit his $15 million salary for the 2026 season. For the Braves, while the loss of a key player is significant, the suspension also provides financial relief, saving the team approximately $18 million due to being over the luxury tax threshold.
The Appeal Process and the Role of the MLBPA
The Major League Baseball Players Association (MLBPA) is challenging the 162-game suspension, indicating a willingness to fight for players’ rights even in cases of positive PED tests. However, as a second-time offender, Profar’s appeal will be expedited but won’t be stayed, meaning the suspension takes effect immediately. This differs from first-time offenders, whose suspensions are typically paused pending the outcome of an appeal.
Beyond Profar: A Broader Glance at PED Trends in Baseball
Jurickson Profar is the sixth player to receive a 162-game ban since the increased penalty for second-time offenders was implemented in 2014. This suggests that despite stricter regulations, PED use remains a concern within the league. The types of substances detected are also evolving, with hCG being identified in Profar’s first suspension and exogenous testosterone in the current case. This indicates players may be seeking more sophisticated methods to evade detection.
Impact on Team Dynamics and Performance
The loss of a player like Profar, who was hitting .245 with 14 home runs and 43 RBIs in 76 games after his previous suspension, significantly impacts the Braves’ roster. The team is already dealing with injuries to starting pitchers Spencer Schwellenbach and Hurston Waldrep, adding to the challenge of maintaining a competitive lineup.
FAQ
Q: What is exogenous testosterone?
A: Exogenous testosterone is testosterone produced outside the body, often used to enhance muscle growth and performance.
Q: What is hCG and why is it banned?
A: Human chorionic gonadotropin (hCG) is a hormone often used after steroid cycles to facilitate restore natural testosterone production. It’s banned given that it can aid in the recovery and continued use of performance-enhancing drugs.
Q: What happens if the MLBPA wins the appeal?
A: If the MLBPA successfully appeals the suspension, the length of the suspension could be reduced, or it could be overturned entirely.
Q: How does a PED suspension affect a player’s future career?
A: A PED suspension can damage a player’s reputation, lead to loss of income, and potentially hinder their ability to secure future contracts.
Did you know? The Braves signed Profar to a three-year, $42 million contract in January 2025, demonstrating the initial faith the team had in his abilities.
Pro Tip: Staying informed about MLB’s drug testing policies is crucial for players and fans alike. MLB provides detailed information on its website regarding prohibited substances and the consequences of violations.
What are your thoughts on MLB’s approach to PEDs? Share your opinions in the comments below! Explore more articles on baseball news and analysis here. Subscribe to our newsletter for the latest updates and insights.
